Effect of Cancer Nurse Navigators on Patient Outcomes

Breast Cancer Clinical Trial

Official title:

Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01902823
• Other study ID #: 11-86E
• Secondary ID: OS11336A545000NU
• Status: Terminated
• Phase: Phase 2/Phase 3
• Start date: November 2011
• Est. completion date: May 2012

Study information

• Verified date: November 2015
• Source: University of Wisconsin, Madison
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

There is widespread anecdotal evidence that Cancer Nurse Navigators (CNNs) are highly valued by cancer patients, but no studies have evaluated the effects of CNNs on important patient-reported outcomes or indicators of quality of care. This study has two aims:

1. To assess the feasibility of studying the impact of Aurora CNN Program.

2. To pilot test the effects of CNN services on patient-reported outcomes and indicators of quality of care.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 16
• Est. completion date: May 2012
• Est. primary completion date: May 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Adult (18 years of age or older)

2. Treated at Aurora St. Luke's or West Allis Medical Center

3. New or recurrent dx of lung, prostate, colorectal or breast cancer -

Exclusion Criteria:

1. Previously received CNN services at an Aurora treatment facility

2. Unable to read/write in English

3. Living in a nursing home/long term care facility

4. Not capable of completing study questionnaires -

Related Conditions & MeSH terms

• Breast Cancer
• Colorectal Cancer
• Colorectal Neoplasms
• Lung Cancer
• Prostate Cancer

Intervention

Behavioral:
• Services from a Nurse Navigator
Services from a Nurse Navigator

Locations

Country	Name	City	State
United States	Aurora St. Luke's Hospital	Milwaukee	Wisconsin
United States	Aurora West Allis	West Allis	Wisconsin

Sponsors (2)

Lead Sponsor	Collaborator
University of Wisconsin, Madison	Aurora Health Care

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Satisfaction with Care		Change from baseline, to 3 months to 6 months
Secondary	ED/Urgent care visits		Baseline, 3 months, 6 months
Secondary	Quality of Life	The Functional Assessment Cancer Therapy - General (FACT-G) assesses quality of life.	Baseline, 3 months, 6 months
Secondary	Distressed mood	The National Comprehensive Cancer Network Distress Thermometer assesses level of distress.	Baseline, 3 months, 6 months
Secondary	Symptom Distress	The Memorial Symptom Assessment Scale measures 32 common physical and psychological cancer-related symptoms.	Baseline, 3 months, 6 months
Secondary	The Inventory of Recent Life Experiences for Cancer Patients	This instrument measures 30 cancer-related irritants (hassles) commonly experienced by persons with cancer.	Baseline, 3 months, 6 months